Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Clemens

Showing results (251-260 of 395) with videos related to

Pageof 40
Sort By:
Gene Therapy|November 1, 1996
In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genesP R Clemens, S Kochanek, Y Sunada, et al.
FEBS Letters|January 2, 1989
Reconstitution of apo-porphobilinogen deaminase: structural changes induced by cofactor bindingA I Scott, K R Clemens, N J Stolowich, et al.
Die Ophthalmologie|January 12, 2024
[Iatrogenic retinal defects after intravitreal operative drug injections]David A Märker, Viola Radeck, Fabian Lehmann, et al.
Vaccine|January 1, 1992
Vaccination against hepatitis A: comparison of different short-term immunization schedulesW Jilg, R Bittner, H L Bock, et al.
Vaccine|January 1, 1992
Immunogenicity, reactogenicity and consistency of a new, inactivated hepatitis A vaccine--a randomized multicentre study with three consecutive vaccine lotsB Kallinowski, K Gmelin, B Kommerell, et al.
Human Gene Therapy|July 31, 1999
Polylysine modification of adenoviral fiber protein enhances muscle cell transductionK Bouri, W G Feero, M M Myerburg, et al.
Anti-Cancer Drugs|April 1, 1997
A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancerC Bokemeyer, C S Lampe, M R Clemens, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|July 6, 2000
[Hepatitis A and hepatitis B seroprevalence in 4 centers in Brazil]S A Clemens, J C da Fonseca, T Azevedo, et al.
Journal of Food Protection|April 3, 2019
Safety Evaluation of Glucose Isomerase Derived from Flavobacterium arborescens and Used in Production of High Fructose Corn SyrupMichael C Porter, Ralph E Hartnagel, Robert L Kowalski, et al.
Toxicology and Applied Pharmacology|May 11, 2007
Immunotoxicity assessment for the novel Spleen tyrosine kinase inhibitor R406Yanhong Zhu, Ellen Herlaar, Esteban S Masuda, et al.
Pageof 40

Showing results (251-260 of 395) with videos related to

Sort By:
Pageof 40
Gene Therapy|November 1, 1996
In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genesP R Clemens, S Kochanek, Y Sunada, et al.
FEBS Letters|January 2, 1989
Reconstitution of apo-porphobilinogen deaminase: structural changes induced by cofactor bindingA I Scott, K R Clemens, N J Stolowich, et al.
Die Ophthalmologie|January 12, 2024
[Iatrogenic retinal defects after intravitreal operative drug injections]David A Märker, Viola Radeck, Fabian Lehmann, et al.
Vaccine|January 1, 1992
Vaccination against hepatitis A: comparison of different short-term immunization schedulesW Jilg, R Bittner, H L Bock, et al.
Vaccine|January 1, 1992
Immunogenicity, reactogenicity and consistency of a new, inactivated hepatitis A vaccine--a randomized multicentre study with three consecutive vaccine lotsB Kallinowski, K Gmelin, B Kommerell, et al.
Human Gene Therapy|July 31, 1999
Polylysine modification of adenoviral fiber protein enhances muscle cell transductionK Bouri, W G Feero, M M Myerburg, et al.
Anti-Cancer Drugs|April 1, 1997
A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancerC Bokemeyer, C S Lampe, M R Clemens, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|July 6, 2000
[Hepatitis A and hepatitis B seroprevalence in 4 centers in Brazil]S A Clemens, J C da Fonseca, T Azevedo, et al.
Journal of Food Protection|April 3, 2019
Safety Evaluation of Glucose Isomerase Derived from Flavobacterium arborescens and Used in Production of High Fructose Corn SyrupMichael C Porter, Ralph E Hartnagel, Robert L Kowalski, et al.
Toxicology and Applied Pharmacology|May 11, 2007
Immunotoxicity assessment for the novel Spleen tyrosine kinase inhibitor R406Yanhong Zhu, Ellen Herlaar, Esteban S Masuda, et al.
Pageof 40